蒲公英 - 制药技术的传播者 GMP理论的实践者

搜索
查看: 1639|回复: 4
收起左侧

[资源分享] 2019药厂审计追踪巡礼 英语讲座 音频

[复制链接]
药师
发表于 2020-1-7 11:34:43 | 显示全部楼层 |阅读模式

欢迎您注册蒲公英

您需要 登录 才可以下载或查看,没有帐号?立即注册

x
Audit Trails – Navigating the Case for Pharma
On today’s episode, Stacey Bruzzese welcomes Matthew LaPierre to talk about Audit Trails. Matthew is a data integrity industry expert.
Stacey and Matthew talk about a variety of topics:
Many Pharma companies view audit trails as the Wild West. Matthew talks about the current landscape of audit trails in Pharma
In an atmosphere where everything is computerized and we have AI and Big Data, why is the industry having such a challenging time tracking and maintaining audit trails?
How do audit trails help in the areas of safety, efficacy, the reliability of pharmaceuticals and ensuring patient safety?
Matthew provides some tips for simplifying the audit trail process
How are improved technologies and systems making data mapping easier to implement?
Where does Matthew see the industry moving on audit trails and what can companies do to get started today?
Mr. LaPierre is an experienced data integrity program manager and industry expert in the field. He has a thorough understanding of not only the foundation and principles of data integrity, but the project management tools and resources needed to execute a truly effective data integrity program at a pharmaceutical site. He is currently engaged worldwide, speaking at conferences and helping companies build programs from the ground up.


Audit Trails – Navigating the Case for Pharma .mp3

31.89 MB, 下载次数: 97

回复

使用道具 举报

药仙
发表于 2020-1-7 11:49:14 | 显示全部楼层
中文都没学好
回复

使用道具 举报

药徒
发表于 2020-1-7 13:41:12 | 显示全部楼层
感谢分享,我这学渣要回去好好翻译一下
回复

使用道具 举报

药徒
发表于 2020-2-4 22:37:43 | 显示全部楼层
谢分享,我这学渣要回去好好翻译一下
回复

使用道具 举报

药王
发表于 2022-9-24 12:31:14 | 显示全部楼层
感谢分享,先收藏
回复

使用道具 举报

您需要登录后才可以回帖 登录 | 立即注册

本版积分规则

×发帖声明
1、本站为技术交流论坛,发帖的内容具有互动属性。您在本站发布的内容:
①在无人回复的情况下,可以通过自助删帖功能随时删除(自助删帖功能关闭期间,可以联系管理员微信:8542508 处理。)
②在有人回复和讨论的情况下,主题帖和回复内容已构成一个不可分割的整体,您将不能直接删除该帖。
2、禁止发布任何涉政、涉黄赌毒及其他违反国家相关法律、法规、及本站版规的内容,详情请参阅《蒲公英论坛总版规》。
3、您在本站发表、转载的任何作品仅代表您个人观点,不代表本站观点。不要盗用有版权要求的作品,转贴请注明来源,否则文责自负。
4、请认真阅读上述条款,您发帖即代表接受上述条款。

QQ|手机版|蒲公英|ouryao|蒲公英 ( 京ICP备14042168号-1 )  增值电信业务经营许可证编号:京B2-20243455  互联网药品信息服务资格证书编号:(京)-非经营性-2024-0033

GMT+8, 2025-9-6 00:20

Powered by Discuz! X3.4

Copyright © 2001-2020, Tencent Cloud.

声明:蒲公英网站所涉及的原创文章、文字内容、视频图片及首发资料,版权归作者及蒲公英网站所有,转载要在显著位置标明来源“蒲公英”;禁止任何形式的商业用途。违反上述声明的,本站及作者将追究法律责任。
快速回复 返回顶部 返回列表